Bruker (BRKR) director Laura Francis granted 4,520 RSUs vesting 2027

Rhea-AI Filing Summary

FRANCIS LAURA reported acquisition or exercise transactions in this Form 4 filing.

Bruker Corporation director Laura Francis received an equity award of 4,520 shares of Common Stock in the form of restricted stock units on February 15, 2026. The RSUs will vest in a single installment on February 15, 2027. After this grant, she holds 9,018 shares directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FRANCIS LAURA

(Last) (First) (Middle)

40 MANNING ROAD

(Street)

BILLERICA MA 01821

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/15/2026		A		4,520(1)	A	$0	9,018	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

	/s/ Michael Simone, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BRKR director Laura Francis report?

Laura Francis reported an equity award of 4,520 restricted stock units in Bruker Corporation Common Stock. The grant is a non-cash award and reflects additional compensation rather than an open-market purchase of shares.

How many Bruker (BRKR) shares was Laura Francis granted?

Laura Francis was granted 4,520 restricted stock units tied to Bruker Common Stock. Each unit is scheduled to convert into one share of Common Stock upon vesting, increasing her potential direct ownership if the vesting conditions are met.

When do Laura Francis’s Bruker RSUs vest and convert to shares?

The restricted stock units granted to Laura Francis will vest in one installment on February 15, 2027. On that vesting date, each RSU will automatically convert into an equal number of Bruker Common Stock shares, according to the grant terms.

Is Laura Francis’s Bruker award an open-market stock purchase?

No, the transaction is a grant of restricted stock units at a stated price of $0.0000 per share. It represents a stock-based compensation award, not a cash purchase of Bruker shares in the open market.

What is Laura Francis’s Bruker share ownership after this grant?

Following the reported grant, Laura Francis directly holds 9,018 shares of Bruker Common Stock. This figure reflects her beneficial ownership immediately after the award transaction disclosed in the insider report.

What type of security was granted to Bruker (BRKR) director Laura Francis?

Laura Francis received restricted stock units that reference Bruker Common Stock. These RSUs do not immediately deliver shares; instead, they convert into the same number of Common Stock shares when the vesting date of February 15, 2027 is reached.